Good point. Unfortunately the Economist article referenced for this number is pay-walled for me and I am not sure if it indicates the total number of clinical trial participants during that time.
I expect 80,000 patients would be at most 1% of population of total clinical trial participants during that 10 year window, so this claim might be a bit over-emphasised (although it does seem striking at first read).
Good point. Unfortunately the Economist article referenced for this number is pay-walled for me and I am not sure if it indicates the total number of clinical trial participants during that time.
Your comment got me interested so I did some quick googling. In the US in 2009 there were 10,974 registered trials with 2.8 Million participants, and in the EU the median number of patients studied for a drug to be approved was 1,708 (during the same time window). I couldn’t quickly find the average length of a clinical trial.
I expect 80,000 patients would be at most 1% of population of total clinical trial participants during that 10 year window, so this claim might be a bit over-emphasised (although it does seem striking at first read).